title: Acute BMP2 upregulation following induction of ischemic osteonecrosis in immature femoral head.
abstract: Juvenile ischemic osteonecrosis of the femoral head (IOFH) is one of the most serious hip conditions causing the femoral head deformity. Little is known about BMP signaling following ischemic osteonecrosis. In this study, we found acute BMP2 upregulation in the femoral head cartilage 24h after ischemic induction using our immature pig IOFH model. Similarly, in our ischemic osteonecrosis mouse model, BMP2 expression and BMP signaling were enhanced in the articular cartilage surrounding the necrotic bone. BMP2 was increased in cartilage explants and primary chondrocytes under hypoxia (1% O(2)) compared with normoxia (21% O(2)). Addition of the hypoxia inducible factor 1 (HIF1) activator DFO significantly increased BMP2 while HIF1 silencing (siHIF1) only partially reduced BMP2, suggesting other mechanisms of BMP2 upregulation being present. Hypoxia is known to induce the production of free oxygen radicals, which are converted to hydrogen peroxide (H(2)O(2)) by superoxide dismutase 2 (SOD2). As an alternative mechanism, we investigated the effect of H(2)O(2)/SOD2 production on BMP2 upregulation. Chondrocytes produced more H(2)O(2) under hypoxia than normoxia. H(2)O(2) addition to the chondrocyte culture also significantly increased BMP2 expression. SOD2 was also dramatically increased in the ischemic pig cartilage at 24h following surgery and in primary chondrocytes/cartilage explants culture under hypoxia. SOD2 protein addition to the chondrocyte culture significantly increased BMP2. Moreover, DFO significantly increased SOD2 while HIF1 silencing only partially reduced SOD2. These results suggest that the acute BMP2 response of chondrocytes to ischemic osteonecrosis is more dominantly through the H(2)O(2) production and only partly through the HIF1 pathway.
authors.affiliation: Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA.
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Kamiya
authors.forename: Sasha
authors.initials: S
authors.lastname: Shafer
authors.forename: Ila
authors.initials: I
authors.lastname: Oxendine
authors.forename: Douglas P
authors.initials: DP
authors.lastname: Mortlock
authors.forename: Ronald L
authors.initials: RL
authors.lastname: Chandler
authors.forename: Leif
authors.initials: L
authors.lastname: Oxburgh
authors.forename: Harry K W
authors.initials: HK
authors.lastname: Kim
mesh_terms: D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D004195:Disease Models, Animal; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007873:Legg-Calve-Perthes Disease / Q000378:metabolism*; D051379:Mice; D020411:Oligonucleotide Array Sequence Analysis; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D013482:Superoxide Dismutase / Q000378:metabolism; D013552:Swine; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D019485:Bone Morphogenetic Proteins; D012333:RNA, Messenger; D006861:Hydrogen Peroxide; D013482:Superoxide Dismutase